Bacterial News and Research

RSS

Free chlamydia testing in pharmacies - questions need addressing

The British Government’s pilot scheme offering free chlamydia testing in pharmacies is to be applauded but a number of issues need to be resolved if it is to be a success, concludes an editorial in this week’s issue of The Lancet.

20 Feb 2005

Safer approach to treating children with cystic fibrosis

Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week’s issue of The Lancet.

10 Feb 2005

Prescription of antibiotics in primary care in Europe vary greatly

Resistance to antibiotics is more common in southern and eastern Europe than in northern Europe because the regions have high rates of antibiotic use, suggests a study published in this week’s issue of The Lancet.

10 Feb 2005

Health risks increase in Guyana with leptospirosis

Leptospirosis has become a health concern in Guyana, as the number of cases continues to rise and 43 people were being treated for suspected cases of the bacterial disease, which is usually caused by exposure to water contaminated with the urine of infected animals.

8 Feb 2005

Research confirms how early-life events shape later physiology

Underscoring the value of good prenatal care, new research suggests that early infection may create a cognitive vulnerability that appears later during stress on the immune system.

8 Feb 2005

Bacterial spread all down to chance: some strains 'just the luckyones'

Scientists have discovered that factors such as human immunity and drug resistance are less important to the success of bacterial spread than previously thought.

3 Feb 2005

Penicillin V and erythromycin have no benefit for most adults with acute laryngitis

Two common antibiotics, Penicillin V and erythromycin, appear to have no benefit for most adults with acute laryngitis, says a research team led by Dr. Ludovic Reveiz of Bogota, Colombia.

24 Jan 2005

New ideas for creating a new generation of oral medications to treat infertility

Researchers now have a much better picture of how follicle-stimulating hormone (FSH), one of the most frequently used fertility drugs, works, and with it new ideas for creating a new generation of oral medications to treat infertility.

20 Jan 2005

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.

17 Jan 2005

Now significantly easier to search long stretches of DNA for genetic changes associated with disease

The researchers developed a method called direct genomic selection that accelerates the transition between family or population-based studies of disease inheritance patterns and identification of genetic variations that may contribute to disease.

6 Jan 2005

Protein discovery with medical implications

It was a transforming moment. Researchers could barely believe their eyes. A molecular blob of a protein reshaped itself into a molecular Pacman in order to free new viruses from the inside of a bacterial cell.

6 Jan 2005

Antibiotics protect nerves in mice by turning on genes

A family of antibiotics that includes penicillin may help prevent nerve damage and death in a wide variety of neurological diseases, including Lou Gehrig's disease, dementia, stroke, and epilepsy, Johns Hopkins researchers have found.

6 Jan 2005

Genomics tools provide clues to what causes 400 million cases of gastrointestinal disease each year

In a study that could benefit medical and food-safety research, scientists have used comparative genomics tools to find clues about why some strains of the bacterium Campylobacter – which each year cause more than 400 million cases of gastrointestinal disease – are more virulent than others.

4 Jan 2005

Multi-state urinary tract infections likely caused by consumption of a contaminated food product of animal origin

A multi-state outbreak of urinary tract infections caused by drug-resistant Escherichia coli was probably due to consumption of a contaminated food product of animal origin, such as meat or milk, according to an article in the Jan. 15 issue of Clinical Infectious Diseases.

4 Jan 2005

For uncomplicated colds antibiotics are not necessary

If a runny nose and congested chest have you thinking of antibiotics, think again.

3 Jan 2005

New findings clarify the role of NOD2, a key molecular player in Crohn's Disease

This week, researchers report new findings that clarify the role of NOD2, a key molecular player in Crohn's Disease, in the cellular signaling pathways that control inflammatory responses. NOD2's clinical relevance is clear from the fact that it is encoded by a Crohn's Disease susceptibility gene.

28 Dec 2004

Evidence suggests that changes in the bacteria and fungi in the gastrointestinal tract can intensify the immune system's reaction to common allergens

If you want to avoid allergies or asthma, scientists at the University of Michigan Medical School suggest you start paying more attention to what's in your gut.

23 Dec 2004

Jumping genes help explain immune system's remarkable ability

A team led by Johns Hopkins scientists has found the first clear evidence that the process behind the human immune system's remarkable ability to recognize and respond to a million different proteins might have originated from a family of genes whose only apparent function is to jump around in genetic material.

22 Dec 2004

Study finds new method can improve chemo survival

Seeking to find a way to lessen patients’ vulnerability to deadly infections following chemotherapy, researchers at the Stanford University School of Medicine have figured out a way to boost the immune function in animals following such treatments.

21 Dec 2004

Study on first new potential drug for tuberculosis in 40 years

454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, announced today that its proprietary whole genome sequencing technology was used by scientists at Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) to help understand the basis of tuberculosis drug resistance.

20 Dec 2004

Bacterial News and Research

Free chlamydia testing in pharmacies - questions need addressing

Safer approach to treating children with cystic fibrosis

Prescription of antibiotics in primary care in Europe vary greatly

Health risks increase in Guyana with leptospirosis

Research confirms how early-life events shape later physiology

Bacterial spread all down to chance: some strains 'just the luckyones'

Penicillin V and erythromycin have no benefit for most adults with acute laryngitis

New ideas for creating a new generation of oral medications to treat infertility

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Now significantly easier to search long stretches of DNA for genetic changes associated with disease

Protein discovery with medical implications

Antibiotics protect nerves in mice by turning on genes

Genomics tools provide clues to what causes 400 million cases of gastrointestinal disease each year

Multi-state urinary tract infections likely caused by consumption of a contaminated food product of animal origin

For uncomplicated colds antibiotics are not necessary

New findings clarify the role of NOD2, a key molecular player in Crohn's Disease

Evidence suggests that changes in the bacteria and fungi in the gastrointestinal tract can intensify the immune system's reaction to common allergens

Jumping genes help explain immune system's remarkable ability

Study finds new method can improve chemo survival

Study on first new potential drug for tuberculosis in 40 years

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News